{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:31:01Z","timestamp":1788413461581,"version":"build-2803163510"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["RF1NS074256"],"award-info":[{"award-number":["RF1NS074256"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["RF1-NS117449"],"award-info":[{"award-number":["RF1-NS117449"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["RF1AG046929"],"award-info":[{"award-number":["RF1AG046929"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["RF1AG058261"],"award-info":[{"award-number":["RF1AG058261"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["RF1AG025493"],"award-info":[{"award-number":["RF1AG025493"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG059124-01A1"],"award-info":[{"award-number":["AG059124-01A1"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["1F30AG081134-01"],"award-info":[{"award-number":["1F30AG081134-01"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["23PRE1027078"],"award-info":[{"award-number":["23PRE1027078"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The accumulation of \u03b2-amyloid (A\u03b2) peptides into insoluble plaques is an early pathological feature of Alzheimer\u2019s disease (AD). BACE1 is the sole \u03b2-secretase for A\u03b2 generation, making it an attractive therapeutic target for AD therapy. While BACE1 inhibitors have been shown to reduce A\u03b2 levels in people with AD, clinical trials targeting BACE1 have failed due to unwanted synaptic deficits. Understanding the physiological role of BACE1 in individual cell types is essential for developing effective BACE inhibitors for the treatment of AD. Recent single-cell RNA transcriptomic assays revealed that oligodendrocytes are enriched with genes required for generating A\u03b2. However, the contribution of oligodendrocytes to amyloid plaque burden in AD and the side effects of oligodendrocyte-specific <jats:italic>Bace1<\/jats:italic> deletion remain to be explored.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We generated an oligodendrocyte-specific <jats:italic>Bace1<\/jats:italic> knockout model (<jats:italic>Bace1<\/jats:italic><jats:sup><jats:italic>fl\/fl<\/jats:italic><\/jats:sup>;<jats:italic>Olig2-Cre<\/jats:italic>) to monitor potential disruptions in myelination using standard electron microscopy. Long-term potentiation (LTP) was monitored to measure synaptic integrity. We crossed the <jats:italic>Bace1<\/jats:italic><jats:sup><jats:italic>fl\/fl<\/jats:italic><\/jats:sup>;<jats:italic>Olig2-Cre<\/jats:italic> model with heterozygous <jats:italic>App<\/jats:italic><jats:sup><jats:italic>NL\u2212G\u2212F\/wt<\/jats:italic><\/jats:sup> knock-in AD mice to generate AD mice lacking oligodendrocyte <jats:italic>Bace1<\/jats:italic> (<jats:italic>Bace1<\/jats:italic><jats:sup><jats:italic>fl\/fl<\/jats:italic><\/jats:sup>;<jats:italic>Olig2-Cre; App<\/jats:italic><jats:sup><jats:italic>NL\u2212G\u2212F\/wt<\/jats:italic><\/jats:sup>) and examined amyloid plaque number and insoluble A\u03b2 levels and gliosis in these animals. Single nuclei RNA sequencing experiments were conducted to examine molecular changes in response to Bace1 deficiency in oligodendrocytes in the wild type or APP knock-in background.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p><jats:italic>Bace1<\/jats:italic> deletion in oligodendrocytes caused no change in myelin thickness in the corpus callosum but a marginal reduction in myelin sheath thickness of the optic nerve. Synaptic strength measured by LTP was not different between <jats:italic>Bace1<\/jats:italic><jats:sup><jats:italic>fl\/fl<\/jats:italic><\/jats:sup>;<jats:italic>Olig2-Cre<\/jats:italic> and age-matched <jats:italic>Bace1<\/jats:italic><jats:sup><jats:italic>fl\/fl<\/jats:italic><\/jats:sup> control animals, suggesting no major effect on synaptic plasticity. Intriguingly, deletion of <jats:italic>Bace1<\/jats:italic> in 12-month-old heterozygous AD knock-in mice (<jats:italic>Bace1<\/jats:italic><jats:sup><jats:italic>fl\/fl<\/jats:italic><\/jats:sup>;<jats:italic>Olig2-Cre; App<\/jats:italic><jats:sup><jats:italic>NL\u2212G\u2212F\/wt<\/jats:italic><\/jats:sup> mice) caused a significant reduction of amyloid plaques by ~\u200933% in the hippocampus and ~\u200929% in the cortex compared to age-matched AD mice (<jats:italic>Bace1<\/jats:italic><jats:sup><jats:italic>fl\/fl<\/jats:italic><\/jats:sup>;<jats:italic>App<\/jats:italic><jats:sup><jats:italic>NL\u2212G\u2212F\/wt<\/jats:italic><\/jats:sup>). Insoluble A\u03b2<jats:sub>1\u201340<\/jats:sub> and A\u03b2<jats:sub>1\u201342<\/jats:sub> levels were reduced comparably while more astrocytes and microglia were observed in surrounding amyloid plaques. Unbiased single-nuclei RNA sequencing results revealed that deletion of oligodendrocyte <jats:italic>Bace1<\/jats:italic> in <jats:italic>APP<\/jats:italic><jats:sup><jats:italic>NL\u2212G\u2212F\/wt<\/jats:italic><\/jats:sup> knock-in mice increased expression of genes associated with A\u03b2 generation and clearance such as <jats:italic>ADAM10<\/jats:italic>, <jats:italic>Ano4<\/jats:italic>,<jats:italic> ApoE<\/jats:italic>, <jats:italic>Il33<\/jats:italic>, and <jats:italic>Sort1<\/jats:italic>.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our results provide compelling evidence that the amyloidogenic pathway in oligodendrocytes contributes to A\u03b2 plaque formation in the AD brain. While specifically targeting BACE1 inhibition in oligodendrocytes for reducing A\u03b2 pathology in AD is likely challenging, this is a potentially explorable strategy in future studies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13024-024-00759-z","type":"journal-article","created":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:04:01Z","timestamp":1731715441000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Contribution of amyloid deposition from oligodendrocytes in a mouse model of Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"19","author":[{"given":"Akihiro","family":"Ishii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Pathoulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"MoustafaFathy Omar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie Y.","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tressa","family":"Pantalena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanxia","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7195-7617","authenticated-orcid":false,"given":"Riqiang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyou","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,16]]},"reference":[{"key":"759_CR1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrneurol.2017.27","volume":"13","author":"D Aarsland","year":"2017","unstructured":"Aarsland D, Creese B, Politis M, Chaudhuri KR, Ffytche DH, Weintraub D, Ballard C. Cognitive decline in Parkinson disease. Nat Rev Neurol. 2017;13:217\u201331.","journal-title":"Nat Rev Neurol"},{"key":"759_CR2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.molmed.2022.11.008","volume":"29","author":"H Bao","year":"2023","unstructured":"Bao H, Shen Y. Unmasking BACE1 in aging and age-related diseases. Trends Mol Med. 2023;29:99\u2013111.","journal-title":"Trends Mol Med"},{"key":"759_CR3","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1152\/physrev.2001.81.2.871","volume":"81","author":"N Baumann","year":"2001","unstructured":"Baumann N, Pham-Dinh D. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev. 2001;81:871\u2013927.","journal-title":"Physiol Rev"},{"key":"759_CR4","doi-asserted-by":"crossref","unstructured":"Becht E, McInnes L, Healy J, Dutertre CA, Kwok IWH, Ng LG, Ginhoux F, Newell EW. Dimensionality reduction for visualizing single-cell data using UMAP. Nat Biotechnol; 2018.","DOI":"10.1038\/nbt.4314"},{"key":"759_CR5","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1093\/hmg\/ddac282","volume":"32","author":"MR Benoit","year":"2023","unstructured":"Benoit MR, Darboe M, Das B, Ge Y, Zhou J, Yao A, He W, Yan R, Hu X. Postnatal neuronal Bace1 deletion impairs neuroblast and oligodendrocyte maturation. Hum Mol Genet. 2023;32:1193\u2013207.","journal-title":"Hum Mol Genet"},{"key":"759_CR6","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41586-022-05439-w","volume":"611","author":"JW Blanchard","year":"2022","unstructured":"Blanchard JW, Akay LA, Davila-Velderrain J, von Maydell D, Mathys H, Davidson SM, Effenberger A, Chen CY, Maner-Smith K, Hajjar I, et al. APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes. Nature. 2022;611:769\u201379.","journal-title":"Nature"},{"key":"759_CR7","doi-asserted-by":"crossref","unstructured":"Bosseboeuf E, Raimondi C. (2020). Signalling, Metabolic Pathways and Iron Homeostasis in Endothelial Cells in Health, Atherosclerosis and Alzheimer\u2019s Disease. Cells 9.","DOI":"10.3390\/cells9092055"},{"key":"759_CR8","doi-asserted-by":"crossref","unstructured":"Chatila ZK, Kim E, Berl\u00e9 C, Bylykbashi E, Rompala A, Oram MK, Gupta D, Kwak SS, Kim YH, Kim DY et al. (2018). BACE1 Regulates Proliferation and Neuronal Differentiation of Newborn Cells in the Adult Hippocampus in Mice. eNeuro 5.","DOI":"10.1523\/ENEURO.0067-18.2018"},{"key":"759_CR9","doi-asserted-by":"crossref","unstructured":"Das B, Singh N, Yao AY, Zhou J, He W, Hu X, Yan R. BACE1 controls synaptic function through modulating release of synaptic vesicles. Mol Psychiatry; 2021.","DOI":"10.1038\/s41380-021-01166-2"},{"key":"759_CR10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s40263-019-00613-7","volume":"33","author":"B Das","year":"2019","unstructured":"Das B, Yan R. A close look at BACE1 inhibitors for Alzheimer\u2019s Disease Treatment. CNS Drugs. 2019;33:251\u201363.","journal-title":"CNS Drugs"},{"key":"759_CR11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41586-023-06120-6","volume":"618","author":"C Depp","year":"2023","unstructured":"Depp C, Sun T, Sasmita AO, Spieth L, Berghoff SA, Nazarenko T, Overhoff K, Steixner-Kumar AA, Subramanian S, Arinrad S, et al. Myelin dysfunction drives amyloid-\u03b2 deposition in models of Alzheimer\u2019s disease. Nature. 2023;618:349\u201357.","journal-title":"Nature"},{"key":"759_CR12","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/glia.21131","volume":"59","author":"MK Desai","year":"2011","unstructured":"Desai MK, Guercio BJ, Narrow WC, Bowers WJ. An Alzheimer\u2019s disease-relevant presenilin-1 mutation augments amyloid-beta-induced oligodendrocyte dysfunction. Glia. 2011;59:627\u201340.","journal-title":"Glia"},{"key":"759_CR13","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13195-019-0520-1","volume":"11","author":"MF Egan","year":"2019","unstructured":"Egan MF, Mukai Y, Voss T, Kost J, Stone J, Furtek C, Mahoney E, Cummings JL, Tariot PN, Aisen PS, et al. Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer\u2019s disease. Alzheimers Res Ther. 2019;11:68.","journal-title":"Alzheimers Res Ther"},{"key":"759_CR14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13024-023-00693-6","volume":"18","author":"G Eskandari-Sedighi","year":"2023","unstructured":"Eskandari-Sedighi G, Blurton-Jones M. Microglial APOE4: more is less and less is more. Mol Neurodegener. 2023;18:99. https:\/\/doi.org\/10.1186\/s13024-024-00759-z.","journal-title":"Mol Neurodegener"},{"key":"759_CR15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13024-022-00566-4","volume":"17","author":"R Fern\u00e1ndez-Calle","year":"2022","unstructured":"Fern\u00e1ndez-Calle R, Konings SC, Fronti\u00f1\u00e1n-Rubio J, Garc\u00eda-Revilla J, Camprub\u00ed-Ferrer L, Svensson M, Martinson I, Boza-Serrano A, Venero JL, Nielsen HM, et al. APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer\u2019s disease pathology and brain diseases. Mol Neurodegener. 2022;17:62.","journal-title":"Mol Neurodegener"},{"key":"759_CR16","doi-asserted-by":"publisher","first-page":"178","DOI":"10.2174\/156720512799361637","volume":"9","author":"D Fleck","year":"2012","unstructured":"Fleck D, Garratt AN, Haass C, Willem M. BACE1 dependent neuregulin processing: review. Curr Alzheimer Res. 2012;9:178\u201383.","journal-title":"Curr Alzheimer Res"},{"key":"759_CR17","doi-asserted-by":"publisher","first-page":"E2705","DOI":"10.1073\/pnas.1604032113","volume":"113","author":"AK Fu","year":"2016","unstructured":"Fu AK, Hung KW, Yuen MY, Zhou X, Mak DS, Chan IC, Cheung TH, Zhang B, Fu WY, Liew FY, et al. IL-33 ameliorates Alzheimer\u2019s disease-like pathology and cognitive decline. Proc Natl Acad Sci U S A. 2016;113:E2705\u20132713.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"759_CR18","doi-asserted-by":"publisher","first-page":"6631","DOI":"10.1523\/JNEUROSCI.6005-11.2012","volume":"32","author":"M Furusho","year":"2012","unstructured":"Furusho M, Dupree JL, Nave KA, Bansal R. Fibroblast growth factor receptor signaling in oligodendrocytes regulates myelin sheath thickness. J Neurosci. 2012;32:6631\u201341.","journal-title":"J Neurosci"},{"key":"759_CR19","doi-asserted-by":"crossref","unstructured":"Hampel H, Vassar R, De Strooper B, Hardy J, Willem M, Singh N, Zhou J, Yan R, Vanmechelen E, De Vos A, et al. The \u03b2-Secretase BACE1 in Alzheimer\u2019s Disease. Biol Psychiatry; 2020.","DOI":"10.1016\/j.biopsych.2020.02.001"},{"key":"759_CR20","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao Y, Hao S, Andersen-Nissen E, Mauck WM 3rd, Zheng S, Butler A, Lee MJ, Wilk AJ, Darby C, Zager M, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184:3573\u201387. e3529.","journal-title":"Cell"},{"key":"759_CR21","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/glia.10178","volume":"41","author":"M Hartlage-R\u00fcbsamen","year":"2003","unstructured":"Hartlage-R\u00fcbsamen M, Zeitschel U, Apelt J, G\u00e4rtner U, Franke H, Stahl T, G\u00fcnther A, Schliebs R, Penkowa M, Bigl V, et al. Astrocytic expression of the Alzheimer\u2019s disease beta-secretase (BACE1) is stimulus-dependent. Glia. 2003;41:169\u201379.","journal-title":"Glia"},{"key":"759_CR22","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1084\/jem.20171831","volume":"215","author":"X Hu","year":"2018","unstructured":"Hu X, Das B, Hou H, He W, Yan R. BACE1 deletion in the adult mouse reverses preformed amyloid deposition and improves cognitive functions. J Exp Med. 2018;215:927\u201340.","journal-title":"J Exp Med"},{"key":"759_CR23","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/jnc.13395","volume":"136","author":"X Hu","year":"2016","unstructured":"Hu X, Fan Q, Hou H, Yan R. Neurological dysfunctions associated with altered BACE1-dependent Neuregulin-1 signaling. J Neurochem. 2016;136:234\u201349.","journal-title":"J Neurochem"},{"key":"759_CR24","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1038\/nn1797","volume":"9","author":"X Hu","year":"2006","unstructured":"Hu X, Hicks CW, He W, Wong P, Macklin WB, Trapp BD, Yan R. Bace1 modulates myelination in the central and peripheral nervous system. Nat Neurosci. 2006;9:1520\u20135.","journal-title":"Nat Neurosci"},{"key":"759_CR25","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1038\/sj.emboj.7601707","volume":"26","author":"X Hu","year":"2007","unstructured":"Hu X, Shi Q, Zhou X, He W, Yi H, Yin X, Gearing M, Levey A, Yan R. Transgenic mice overexpressing reticulon 3 develop neuritic abnormalities. EMBO J. 2007;26:2755\u201367.","journal-title":"EMBO J"},{"key":"759_CR26","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1006\/mcne.1999.0811","volume":"14","author":"I Hussain","year":"1999","unstructured":"Hussain I, Powell D, Howlett DR, Tew DG, Meek TD, Chapman C, Gloger IS, Murphy KE, Southan CD, Ryan DM, et al. Identification of a novel aspartic protease (asp 2) as beta-secretase. Mol Cell Neurosci. 1999;14:419\u201327.","journal-title":"Mol Cell Neurosci"},{"key":"759_CR27","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41573-022-00391-w","volume":"21","author":"E Karran","year":"2022","unstructured":"Karran E, De Strooper B. The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics. Nat Rev Drug Discov. 2022;21:306\u201318.","journal-title":"Nat Rev Drug Discov"},{"key":"759_CR28","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/s41593-022-01104-7","volume":"25","author":"M Kenigsbuch","year":"2022","unstructured":"Kenigsbuch M, Bost P, Halevi S, Chang Y, Chen S, Ma Q, Hajbi R, Schwikowski B, Bodenmiller B, Fu H, et al. A shared disease-associated oligodendrocyte signature among multiple CNS pathologies. Nat Neurosci. 2022;25:876\u201386.","journal-title":"Nat Neurosci"},{"key":"759_CR29","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, Baglaenko Y, Brenner M, Loh PR, Raychaudhuri S. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods. 2019;16:1289\u201396.","journal-title":"Nat Methods"},{"key":"759_CR30","doi-asserted-by":"crossref","unstructured":"Leitzke S, Seidel J, Ahrens B, Schreiber R, Kunzelmann K, Sperrhacke M, Bhakdi S, Reiss K. (2022). Influence of Anoctamin-4 and \u2013\u20099 on ADAM10 and ADAM17 sheddase function. Membranes (Basel) 12.","DOI":"10.3390\/membranes12020123"},{"key":"759_CR31","doi-asserted-by":"publisher","first-page":"741175","DOI":"10.3389\/fgene.2021.741175","volume":"12","author":"KH Lim","year":"2021","unstructured":"Lim KH, Yang S, Kim SH, Joo JY. Identifying New COVID-19 receptor Neuropilin-1 in severe Alzheimer\u2019s Disease patients Group Brain using genome-wide Association Study Approach. Front Genet. 2021;12:741175.","journal-title":"Front Genet"},{"key":"759_CR32","doi-asserted-by":"publisher","first-page":"19877","DOI":"10.1038\/s41598-019-56329-7","volume":"9","author":"S Lombardo","year":"2019","unstructured":"Lombardo S, Chiacchiaretta M, Tarr A, Kim W, Cao T, Sigal G, Rosahl TW, Xia W, Haydon PG, Kennedy ME, et al. BACE1 partial deletion induces synaptic plasticity deficit in adult mice. Sci Rep. 2019;9:19877.","journal-title":"Sci Rep"},{"key":"759_CR33","doi-asserted-by":"publisher","first-page":"17967","DOI":"10.1073\/pnas.0605461103","volume":"103","author":"J Majercak","year":"2006","unstructured":"Majercak J, Ray WJ, Espeseth A, Simon A, Shi XP, Wolffe C, Getty K, Marine S, Stec E, Ferrer M, et al. LRRTM3 promotes processing of amyloid-precursor protein by BACE1 and is a positional candidate gene for late-onset Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2006;103:17967\u201372.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"759_CR34","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.neuron.2022.03.004","volume":"110","author":"YA Martens","year":"2022","unstructured":"Martens YA, Zhao N, Liu CC, Kanekiyo T, Yang AJ, Goate AM, Holtzman DM, Bu G. ApoE Cascade Hypothesis in the pathogenesis of Alzheimer\u2019s disease and related dementias. Neuron. 2022;110:1304\u201317.","journal-title":"Neuron"},{"key":"759_CR35","doi-asserted-by":"crossref","unstructured":"McDade E, Voytyuk I, Aisen P, Bateman RJ, Carrillo MC, De Strooper B, Haass C, Reiman EM, Sperling R, Tariot PN, et al. The case for low-level BACE1 inhibition for the prevention of Alzheimer disease. Nat Rev Neurol; 2021.","DOI":"10.1038\/s41582-021-00545-1"},{"key":"759_CR36","doi-asserted-by":"publisher","first-page":"779125","DOI":"10.3389\/fnins.2021.779125","volume":"15","author":"DMS Moura","year":"2021","unstructured":"Moura DMS, Brennan EJ, Brock R, Cocas LA. Neuron to Oligodendrocyte Precursor Cell synapses: protagonists in Oligodendrocyte Development and Myelination, and targets for therapeutics. Front Neurosci. 2021;15:779125.","journal-title":"Front Neurosci"},{"key":"759_CR37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13024-023-00596-6","volume":"18","author":"SA M\u00fcller","year":"2023","unstructured":"M\u00fcller SA, Shmueli MD, Feng X, T\u00fcshaus J, Schumacher N, Clark R, Smith BE, Chi A, Rose-John S, Kennedy ME, et al. The Alzheimer\u2019s disease-linked protease BACE1 modulates neuronal IL-6 signaling through shedding of the receptor gp130. Mol Neurodegener. 2023;18:13.","journal-title":"Mol Neurodegener"},{"key":"759_CR38","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40478-018-0515-3","volume":"6","author":"SE Nasrabady","year":"2018","unstructured":"Nasrabady SE, Rizvi B, Goldman JE, Brickman AM. White matter changes in Alzheimer\u2019s disease: a focus on myelin and oligodendrocytes. Acta Neuropathol Commun. 2018;6:22.","journal-title":"Acta Neuropathol Commun"},{"key":"759_CR39","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13195-020-00614-5","volume":"12","author":"G Novak","year":"2020","unstructured":"Novak G, Streffer JR, Timmers M, Henley D, Brashear HR, Bogert J, Russu A, Janssens L, Tesseur I, Tritsmans L, et al. Long-term safety and tolerability of atabecestat (JNJ-54861911), an oral BACE1 inhibitor, in early Alzheimer\u2019s disease spectrum patients: a randomized, double-blind, placebo-controlled study and a two-period extension study. Alzheimers Res Ther. 2020;12:58.","journal-title":"Alzheimers Res Ther"},{"key":"759_CR40","doi-asserted-by":"crossref","unstructured":"Ou-Yang MH, Kurz JE, Nomura T, Popovic J, Rajapaksha TW, Dong H, Contractor A, Chetkovich DM, Tourtellotte WG, Vassar R. (2018). Axonal organization defects in the hippocampus of adult conditional BACE1 knockout mice. Science translational medicine 10.","DOI":"10.1126\/scitranslmed.aao5620"},{"key":"759_CR41","doi-asserted-by":"crossref","unstructured":"Pratsch K, Unemura C, Ito M, Lichtenthaler SF, Horiguchi N, Herms J. (2023). New highly selective BACE1 inhibitors and their effects on dendritic spine density in vivo. Int J Mol Sci 24.","DOI":"10.3390\/ijms241512283"},{"key":"759_CR42","doi-asserted-by":"publisher","first-page":"e3002727","DOI":"10.1371\/journal.pbio.3002727","volume":"22","author":"RM Rajani","year":"2024","unstructured":"Rajani RM, Ellingford R, Hellmuth M, Harris SS, Taso OS, Graykowski D, Lam FKW, Arber C, Fertan E, Danial JSH, et al. Selective suppression of oligodendrocyte-derived amyloid beta rescues neuronal dysfunction in Alzheimer\u2019s disease. PLoS Biol. 2024;22:e3002727.","journal-title":"PLoS Biol"},{"key":"759_CR43","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13024-022-00574-4","volume":"17","author":"AC Raulin","year":"2022","unstructured":"Raulin AC, Doss SV, Trottier ZA, Ikezu TC, Bu G, Liu CC. ApoE in Alzheimer\u2019s disease: pathophysiology and therapeutic strategies. Mol Neurodegener. 2022;17:72.","journal-title":"Mol Neurodegener"},{"key":"759_CR68","doi-asserted-by":"publisher","unstructured":"Rossi A, Bovenkamp D. (2024) Are oligodendrocytes the missing link in Alzheimer\u2019s disease and related dementias research? Mol Neurodegener 19. https:\/\/doi.org\/10.1186\/s13024-024-00760-6.","DOI":"10.1186\/s13024-024-00760-6"},{"key":"759_CR44","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1471-4159.2004.02857.x","volume":"92","author":"S Rossner","year":"2005","unstructured":"Rossner S, Lange-Dohna C, Zeitschel U, Perez-Polo JR. Alzheimer\u2019s disease beta-secretase BACE1 is not a neuron-specific enzyme. J Neurochem. 2005;92:226\u201334.","journal-title":"J Neurochem"},{"key":"759_CR45","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.expneurol.2017.10.018","volume":"299","author":"CS Ruan","year":"2018","unstructured":"Ruan CS, Liu J, Yang M, Saadipour K, Zeng YQ, Liao H, Wang YJ, Bobrovskaya L, Zhou XF. Sortilin inhibits amyloid pathology by regulating non-specific degradation of APP. Exp Neurol. 2018;299:75\u201385.","journal-title":"Exp Neurol"},{"key":"759_CR46","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nn.3697","volume":"17","author":"T Saito","year":"2014","unstructured":"Saito T, Matsuba Y, Mihira N, Takano J, Nilsson P, Itohara S, Iwata N, Saido TC. Single app knock-in mouse models of Alzheimer\u2019s disease. Nat Neurosci. 2014;17:661\u20133.","journal-title":"Nat Neurosci"},{"key":"759_CR47","doi-asserted-by":"crossref","unstructured":"Sasmita AO, Depp C, Nazarenko T, Sun T, Siems SB, Ong EC, Nkeh YB, B\u00f6hler C, Yu X, Bues B, et al. Oligodendrocytes produce amyloid-\u03b2 and contribute to plaque formation alongside neurons in Alzheimer\u2019s disease model mice. Nat Neurosci; 2024.","DOI":"10.1038\/s41593-024-01730-3"},{"key":"759_CR48","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nbt.3192","volume":"33","author":"R Satija","year":"2015","unstructured":"Satija R, Farrell JA, Gennert D, Schier AF, Regev A. Spatial reconstruction of single-cell gene expression data. Nat Biotechnol. 2015;33:495\u2013502.","journal-title":"Nat Biotechnol"},{"key":"759_CR49","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13024-021-00464-1","volume":"16","author":"MG Sharoar","year":"2021","unstructured":"Sharoar MG, Palko S, Ge Y, Saido TC, Yan R. Accumulation of saposin in dystrophic neurites is linked to impaired lysosomal functions in Alzheimer\u2019s disease brains. Mol Neurodegener. 2021;16:45.","journal-title":"Mol Neurodegener"},{"key":"759_CR50","doi-asserted-by":"publisher","first-page":"eabo1286","DOI":"10.1126\/sciadv.abo1286","volume":"8","author":"N Singh","year":"2022","unstructured":"Singh N, Benoit MR, Zhou J, Das B, Davila-Velderrain J, Kellis M, Tsai LH, Hu X, Yan R. BACE-1 inhibition facilitates the transition from homeostatic microglia to DAM-1. Sci Adv. 2022a;8:eabo1286.","journal-title":"Sci Adv"},{"key":"759_CR51","doi-asserted-by":"crossref","unstructured":"Singh N, Das B, Zhou J, Hu X, Yan R. (2022). Targeted BACE-1 inhibition in microglia enhances amyloid clearance and improved cognitive performance. Sci Adv 8, eabo3610.","DOI":"10.1126\/sciadv.abo3610"},{"key":"759_CR52","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/990114","volume":"402","author":"S Sinha","year":"1999","unstructured":"Sinha S, Anderson JP, Barbour R, Basi GS, Caccavello R, Davis D, Doan M, Dovey HF, Frigon N, Hong J, et al. Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature. 1999;402:537\u201340.","journal-title":"Nature"},{"key":"759_CR53","doi-asserted-by":"crossref","unstructured":"Taylor HA, Przemylska L, Clavane EM, Meakin PJ. (2022). BACE1: more than just a \u03b2-secretase. Obes Rev 23, e13430.","DOI":"10.1111\/obr.13430"},{"key":"759_CR54","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.neurobiolaging.2020.05.016","volume":"94","author":"I Vanzulli","year":"2020","unstructured":"Vanzulli I, Papanikolaou M, De-La-Rocha IC, Pieropan F, Rivera AD, Gomez-Nicola D, Verkhratsky A, Rodr\u00edguez JJ, Butt AM. Disruption of oligodendrocyte progenitor cells is an early sign of pathology in the triple transgenic mouse model of Alzheimer\u2019s disease. Neurobiol Aging. 2020;94:130\u20139.","journal-title":"Neurobiol Aging"},{"key":"759_CR55","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1126\/science.286.5440.735","volume":"286","author":"R Vassar","year":"1999","unstructured":"Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DB, Ross S, Amarante P, Loeloff R, et al. Beta-secretase cleavage of Alzheimer\u2019s amyloid precursor protein by the transmembrane aspartic protease BACE. Science. 1999;286:735\u201341.","journal-title":"Science"},{"key":"759_CR56","doi-asserted-by":"publisher","first-page":"8677","DOI":"10.1523\/JNEUROSCI.2440-08.2008","volume":"28","author":"H Wang","year":"2008","unstructured":"Wang H, Song L, Laird F, Wong PC, Lee HK. BACE1 knock-outs display deficits in activity-dependent potentiation of synaptic transmission at mossy fiber to CA3 synapses in the hippocampus. J Neurosci. 2008;28:8677\u201381.","journal-title":"J Neurosci"},{"key":"759_CR57","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13024-022-00517-z","volume":"17","author":"M Wang","year":"2022","unstructured":"Wang M, Song WM, Ming C, Wang Q, Zhou X, Xu P, Krek A, Yoon Y, Ho L, Orr ME, et al. Guidelines for bioinformatics of single-cell sequencing data analysis in Alzheimer\u2019s disease: review, recommendation, implementation and application. Mol Neurodegener. 2022a;17:17.","journal-title":"Mol Neurodegener"},{"key":"759_CR58","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13024-022-00577-1","volume":"17","author":"N Wang","year":"2022","unstructured":"Wang N, Wang M, Jeevaratnam S, Rosenberg C, Ikezu TC, Shue F, Doss SV, Alnobani A, Martens YA, Wren M, et al. Opposing effects of apoE2 and apoE4 on microglial activation and lipid metabolism in response to demyelination. Mol Neurodegener. 2022b;17:75.","journal-title":"Mol Neurodegener"},{"key":"759_CR59","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1126\/science.1132341","volume":"314","author":"M Willem","year":"2006","unstructured":"Willem M, Garratt AN, Novak B, Citron M, Kaufmann S, Rittger A, DeStrooper B, Saftig P, Birchmeier C, Haass C. Control of peripheral nerve myelination by the beta-secretase BACE1. Science. 2006;314:664\u20136.","journal-title":"Science"},{"key":"759_CR60","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","volume":"186","author":"DM Wilson 3rd","year":"2023","unstructured":"Wilson DM 3rd, Cookson MR, Van Den Bosch L, Zetterberg H, Holtzman DM, Dewachter I. Hallmarks of neurodegenerative diseases. Cell. 2023;186:693\u2013714.","journal-title":"Cell"},{"key":"759_CR61","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, Feng T, Zhou L, Tang W, Zhan L, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innov (Camb). 2021;2:100141.","journal-title":"Innov (Camb)"},{"key":"759_CR62","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/990107","volume":"402","author":"R Yan","year":"1999","unstructured":"Yan R, Bienkowski MJ, Shuck ME, Miao H, Tory MC, Pauley AM, Brashier JR, Stratman NC, Mathews WR, Buhl AE, et al. Membrane-anchored aspartyl protease with Alzheimer\u2019s disease beta-secretase activity. Nature. 1999;402:533\u20137.","journal-title":"Nature"},{"key":"759_CR63","doi-asserted-by":"crossref","unstructured":"Young-Pearse TL, Lee H, Hsieh YC, Chou V, Selkoe DJ. Moving beyond amyloid and tau to capture the biological heterogeneity of Alzheimer\u2019s disease. Trends Neurosci; 2023.","DOI":"10.1016\/j.tins.2023.03.005"},{"key":"759_CR64","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.stem.2010.04.002","volume":"6","author":"M Zawadzka","year":"2010","unstructured":"Zawadzka M, Rivers LE, Fancy SP, Zhao C, Tripathi R, Jamen F, Young K, Goncharevich A, Pohl H, Rizzi M, et al. CNS-resident glial progenitor\/stem cells produce Schwann cells as well as oligodendrocytes during repair of CNS demyelination. Cell Stem Cell. 2010;6:578\u201390.","journal-title":"Cell Stem Cell"},{"key":"759_CR65","doi-asserted-by":"publisher","first-page":"14049","DOI":"10.1038\/ncomms14049","volume":"8","author":"GX Zheng","year":"2017","unstructured":"Zheng GX, Terry JM, Belgrader P, Ryvkin P, Bent ZW, Wilson R, Ziraldo SB, Wheeler TD, McDermott GP, Zhu J, et al. Massively parallel digital transcriptional profiling of single cells. Nat Commun. 2017;8:14049.","journal-title":"Nat Commun"},{"key":"759_CR66","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13024-023-00611-w","volume":"18","author":"J Zhou","year":"2023","unstructured":"Zhou J, Singh N, Galske J, Hudobenko J, Hu X, Yan R. BACE1 regulates expression of Clusterin in astrocytes for enhancing clearance of \u03b2-amyloid peptides. Mol Neurodegener. 2023;18:31.","journal-title":"Mol Neurodegener"},{"key":"759_CR67","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.biopsych.2018.04.022","volume":"84","author":"K Zhu","year":"2018","unstructured":"Zhu K, Peters F, Filser S, Herms J. Consequences of pharmacological BACE inhibition on synaptic structure and function. Biol Psychiatry. 2018;84:478\u201387.","journal-title":"Biol Psychiatry"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-024-00759-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-024-00759-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-024-00759-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T08:05:06Z","timestamp":1731744306000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-024-00759-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,16]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["759"],"URL":"https:\/\/doi.org\/10.1186\/s13024-024-00759-z","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,16]]},"assertion":[{"value":"26 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental protocols were approved by the Institutional Animal Care and Use Committee of the University of Connecticut School of Medicine in compliance with the guidelines established by the Public Health Service Guide for the Care and Use of Laboratory Animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent to participate"}},{"value":"All authors have read and approved the final manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no conflict of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"83"}}